METABIOTICS
PRESENT STATE, CHALLENGES AND PERSPECTIVES
Book
Chapter
Commercially available metabiotics can be divided according to their composition into dietary supplements, functional and personal foods, therapeutics, cosmetic products (liquid, dry, pastes, creams etc.); pha...
Chapter
From the contemporary perspective, the human organism should be viewed as the most complex “superorganism”, a symbiotic community of eukaryotic, prokaryotic cells including archaebacteria, and viruses (Ugolev ...
Chapter
Different techniques and analytical technologies are used for identification of compoundspotentially suitable for constructing various metabiotics. Their choice depends on analytical purposes, qualitative and/...
Chapter
According to the contemporary data, the daily needs of the human organism required for construction and functioning of millions of simple and complex molecular entities amount to over 20 thousand of different ...
Chapter
In the last decade, some metabiotics have been launched on the markets of a number of countries including the Russian Federation, whose production includes natural (or artificial) bioactive molecules similar o...
Chapter
According to the latest data, human microbiome variability is only by 10% related to individual genetic traits; microbiome differences between individuals are largely associated with the effects of various end...
Chapter
The analysis of contemporary literature bears evidence that the development of therapeutics intended for optimum formation, preservation and restoration of human symbiotic microbiota and their practical implem...
Chapter
Microorganisms are starters of the nascence and subsequent evolution of all biological life varieties on our planet including humans. A contemporary view of a human organism presents it as a superorganism, a d...
Chapter
The knowledge of molecular language of symbiotic (probiotic) microorganisms allows for a more intensive and targeted development of the next generation of probiotics and functional foods. In our opinion, the d...
Chapter
Microorganisms are essentially the main “workhorses” of contemporary biotechnology. It should be noted that a large proportion of microorganism strains existing in nature, including many representatives of ana...
Chapter
Symbiotic microorganisms ever-present in the organisms of adult people form over 25 thousand different biologically and pharmacologically active compounds. With regard to potential biological effects, the most...
Chapter
For health preservation and reducing the risk of premature ageing and related metabolic diseases, human diet should include various traditional, organic and functional foods as well as therapeutics that suppor...
Chapter
The growing market of pharmaceuticals, dietary supplements, and particularly food products based on live probiotic microorganisms, is evidence of their sufficient prophylactic and, if less marked, therapeutic ...
Chapter
In the 1990s, it was found that various microorganisms, their cell fragments, colloid particles, food starch granules and other compounds similar in size to bacterial cells or smaller can easily penetrate inte...
Chapter
As regards cell quantitative content, a human being is essentially a more prokaryotic than eukaryotic organism. Great success has been achieved in the characterization of microorganisms inhabiting the human be...
Chapter
To provide a clearer picture of what modern techniques and technologies are used when develo** metabiotics and launching them on the market of therapeutics and functional foods, let us describe how metabioti...
Chapter
Tables 1, 2, 3, 4, 5, 6, 7 and 8 show some new targets and approaches to the use of low molecular microbial molecules for the development and production of essentially new metabiotics in order to prevent and t...
Article
The intracellular apicomplexan parasite Toxoplasma gondii is able to survive and persist in immunocompetent intermediate hosts for the host’s life span. This is despite the induction of a vigorous humoral and—mor...
Article
We have analyzed the intracellular behavior of the human transferrin receptor (TfR) in Saccharomyces cerevisiae. The major part of the heterologously expressed TfR, which has previously been used as a model for h...